Small intestinal bacterial overgrowth, or SIBO, means excessive numbers of bacteria in the small bowel causing gastrointestinal symptoms, most often bloating, gas, abdominal pain and altered bowel habits. It is usually diagnosed with a hydrogen and methane breath test, usually treated with a course of antibiotics, and it frequently comes back. In one follow-up study of patients successfully treated with rifaximin, breath test positivity had returned in 43.7 percent of them by nine months. That relapse rate is the part most articles leave out, and it should shape how you think about testing in the first place.
The definition is less settled than the marketing suggests
The 2020 AGA Clinical Practice Update on SIBO states plainly that the definition of SIBO lacks precision and consistency, and that its true prevalence is therefore undefined. The same review notes that the role of SIBO in causing common functional symptoms, including those grouped under irritable bowel syndrome, remains controversial.
The American College of Gastroenterology published a full clinical guideline on SIBO the same year using formal GRADE methodology, and where the evidence was not strong enough for a graded recommendation the authors fell back on expert consensus.
Both things are true at once. SIBO is a real clinical entity, particularly in people with an anatomical, surgical or motility reason for bacteria to accumulate where they should not. It is also a label applied far more widely than the evidence supports.
What a breath test actually measures
A breath test does not count bacteria. You drink a sugar solution, then the test measures hydrogen and methane in your breath over the following hours. Those gases come from microbes fermenting the sugar. Human cells do not produce them, so their appearance is real information, just indirect information.
The 2017 North American Consensus on breath testing standardized how these tests are run and read. The agreed doses are 75 g for glucose and 10 g for lactulose. A rise in hydrogen of 20 ppm or more above baseline within 90 minutes is considered positive for SIBO, and methane of 10 ppm or more at any point is considered methane positive.
Limits worth knowing before you pay for a test:
- Gas tells you fermentation happened. It does not say where in the bowel.
- A lactulose test can turn positive simply because the sugar reached the colon quickly. Fast transit imitates overgrowth.
- Preparation drives the result. Recent antibiotics, probiotics, promotility medication and the day-before diet all move the curve.
- Small bowel aspirate and culture is the reference standard, but it needs an endoscopy, samples a single spot, and is not routine.
- The AGA update states there is insufficient evidence to use markers such as fecal calprotectin to detect SIBO.
Methane deserves a separate note. It is produced by archaea rather than bacteria, and methane positive results track more closely with constipation than diarrhea. Many clinicians now call that pattern intestinal methanogen overgrowth instead of SIBO, because it is a different organism behaving like a different problem. If your report says methane, the word bacterial in the acronym is already inaccurate for you.
Treatment, and how thin the evidence underneath it is
Rifaximin is the antibiotic most often prescribed. Its FDA-approved labeling lists three indications: travelers’ diarrhea caused by noninvasive strains of E. coli, reducing the risk of overt hepatic encephalopathy recurrence, and irritable bowel syndrome with diarrhea. SIBO is not among them. Prescribing it for SIBO is off-label, which is legal and common, but you should be told that rather than left to assume otherwise.
The AGA review is equally direct: there is a limited database to guide antibiotic strategy for SIBO in any context, therapy remains largely empiric, and prescribers must stay mindful of the risks of repeated broad-spectrum antibiotics. It advises that management focus on identifying and correcting the underlying cause where possible, alongside any nutritional deficiencies.
Diet has a supporting role, not a starring one. A short, structured trial of reduced fermentable carbohydrates can lower symptom load while the underlying issue is addressed. An open-ended restrictive diet is a different thing and it does harm: it narrows nutrition, starves the microbial diversity you want to protect, and carries a real disordered eating risk.
The relapse problem
This is the honest center of the topic. In a study of 80 patients treated with rifaximin and confirmed clear on glucose breath testing, positivity had returned in 12.6 percent at three months, 27.5 percent at six months and 43.7 percent at nine months, with symptoms returning alongside the test results. Older age, previous appendectomy and chronic proton pump inhibitor use were all associated with recurrence.
Read that as a clue rather than a defeat. Bacteria return when the conditions that let them accumulate are still in place: slowed motility, low stomach acid, altered anatomy after surgery, an incompetent ileocecal valve, or a condition such as diabetes or scleroderma affecting gut movement. Treating the overgrowth without addressing the reason for it is a loop, and repeated antibiotic courses are not a neutral way to spend the years.
When SIBO is the wrong answer
Before accepting the diagnosis, the conditions that mimic it need excluding. Celiac disease, exocrine pancreatic insufficiency, carbohydrate maldigestion such as lactose or fructose intolerance, thyroid disease, medication effects from opioids or long-term acid suppression, and irritable bowel syndrome itself all produce overlapping symptoms. A positive breath test in someone never worked up for these does not rule them out. Our piece on bloating covers that differential, and what a GI-MAP test shows explains why a stool panel answers a different question than a breath test.
Red flags that need a doctor, not a test kit
Book proper evaluation rather than an online panel if you have blood in your stool, unintentional weight loss, iron deficiency anemia, fever, vomiting, symptoms that wake you at night, greasy or floating stools, a family history of colorectal cancer or inflammatory bowel disease, or new bowel symptoms after about age 45. These are not SIBO patterns and they need looking at directly.
How we approach it
At MetaHealth we start with why, not with a test: a proper history, checking the mimics, reviewing medications that slow motility or suppress acid, and only then deciding whether a breath test would change the plan. If it would not change what we do next, we do not order it. Our gut health and functional medicine consults are available in person in Deerfield Beach and by telehealth across Florida, in English, Portuguese and Spanish.
Medically reviewed by Krishna Borges, MSN, APRN, FNP-C. This article is for general education and is not a substitute for individual medical advice.